Free delivery nationwide for orders above ₱800

RXDRUG-DR-XY47571-1pc

TERAZIDINE Trimetazidine 35mg - 1 Tablet

Selling for 1000
In stock
+
Add to wish list
No prescription? No problem!
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies

All variations

  Dosage Packaging Availability Price  
Image of TERAZIDINE TRIMETAZIDINE 35MG - 1 TABLET 35 mg Modified-Release Tablet 1's
In stock
1000
+
Description

Indications / Uses

TERAZIDINE Trimetazidine 35mg is used for the symptomatic treatment of stable angina pectoris in adult patients, particularly when the chest pain is not adequately controlled by other first-line anti-anginal agents. This medication is often employed as an add-on therapy to existing treatment regimens to help improve exercise tolerance and reduce the frequency of angina attacks. It works as a metabolic agent, protecting heart cells from the effects of ischemia (lack of oxygen). The 35 mg strength is a modified-release formulation designed to provide sustained therapeutic effect over a prolonged period.

Formulation / Ingredients
TERAZIDINE Trimetazidine 35mg contains: Trimetazidine Hydrochloride 35mg

Do I need prescription to buy TERAZIDINE Trimetazidine 35mg?

Yes, you need a prescription. But if you don't have one, you can get a free teleconsultation from MedsGo Physician. Just make an order and our Physician will call you back.

Side Effects

TERAZIDINE Trimetazidine 35mg common side effects include headache and dizziness, as well as general weakness or feelings of tiredness. Gastrointestinal disturbances are also frequent, presenting as nausea, vomiting, or discomfort in the abdomen. Although rare, more serious adverse effects can manifest as movement disorders, including symptoms similar to Parkinson's disease, such as tremors, rigid posture, or difficulty walking. Additionally, skin reactions like rashes and hives have been reported in some individuals.

Directions and Dosage

  • Dosage for Adults (18+ years): 35 mg taken twice daily, once in the morning and once in the evening.
  • Dosage for Patients with Moderate Kidney Impairment: A lower dose of 35 mg taken once daily is typically advised.

The maximum daily dosage is generally 70 mg. This medication is not recommended for individuals under 18 years of age due to insufficient data on efficacy and safety.

Contraindications

This medicine is restricted for use in individuals with a known allergy to the active component or any constituent of the tablet. It is strictly prohibited for patients who have pre-existing movement disorders, including tremors, restlessness in the legs, or symptoms resembling Parkinson's disease. Severe impairment of kidney function also restricts the use of this treatment.

Use in Pregnancy and Lactation

Safety data regarding the use of this medication during gestation are currently insufficient. Therefore, its administration is not recommended during this period unless the benefits are clearly established. It is unknown whether the active substance is transferred into human milk; consequently, use during nursing is not advised.

Special Precautions

  • Exercise extreme caution, particularly in elderly patients, due to the potential for increased systemic exposure.
  • The medication may initiate or exacerbate existing movement disorders, requiring immediate cessation if such symptoms appear.
  • Use carefully in individuals with kidney problems; the dose may need adjustment based on the degree of impairment.

Is it safe to take it with other medications?

No known severe interactions have been reported with common cardiovascular medications. However, co-administration with other treatments affecting the central nervous system may require careful consideration due to the potential risk of developing or worsening movement disorders.

How should I store it?

Store the tablets at temperatures not exceeding 30°C. Keep them protected from light, moisture, and ensure they remain securely out of the reach of children.

Used For
Stable Angina
Age
Adults

Features

Dosage
35 mg
Ingredients
  • Trimetazidine
Packaging
Modified-Release Tablet 1's
Generic Name
Trimetazidine Hydrochloride
Registration Number
DR-XY47571
Classification
Prescription Drug (RX)
Find similar

Reviews

No reviews found

Product Questions

Questions